Browsing publications by Professor Ruth Plummer

Newcastle AuthorsTitleYear
Professor Ruth Plummer
DOC-MEK: a double-blind randomized phase II trial of docetaxel with or without selumetinib in wild-type BRAF advanced melanoma2014
James Murray
Huw Thomas
Philip Berry
Suzanne Kyle
Dr Miranda Patterson
et al.
Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedules2014
Dr Graeme O'Boyle
Isabella Swidenbank
Dr Helen Marshall
Catriona Barker
Dr Jane Armstrong
et al.
Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by AMD110702013
Professor Ruth Plummer
Inhibitor of ATR (Ataxia Telangiectasia and RAD3 Related) Kinase2013
Dr Ahmed Elattar
Dr Asima Mukhopadhyay
Dr Fadhel Shaheen
Professor Ruth Plummer
Professor Craig Robson
et al.
Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer2012
Dr Asima Mukhopadhyay
Professor Ruth Plummer
Dr Ahmed Elattar
Dr San Soo Hoo
Bisha Uzir
et al.
Clinicopathological features of homologous recombination deficient epithelial ovarian cancers: Sensitivity to PARP inhibitors, platinum and survival2012
Dr Asima Mukhopadhyay
Professor Ruth Plummer
Dr Ahmed Elattar
Dr San Soo Hoo
Bisha Uzir
et al.
Clinicopathological features of homologous recombination deficient epithelial ovarian cancers: Sensitivity to PARP inhibitors, platinum and survival2012
Dr Asima Mukhopadhyay
Professor Ruth Plummer
Dr Ahmed Elattar
Dr San Soo Hoo
Bisha Uzir
et al.
Clinicopathological Features of Homologous Recombination-Deficient Epithelial Ovarian Cancers: Sensitivity to PARP Inhibitors, Platinum, and Survival2012
Dr Aiste McCormick
Dr Asima Mukhopadhyay
Professor Ruth Plummer
Professor Nicola Curtin
Professor Richard Edmondson
et al.
Defective homologous recombination in human cancers2012
Dr Britta Vormoor
Sarah Wilkinson
Fiona Harvey
Professor Ruth Plummer
Professor Nicola Curtin
et al.
Ewing's Sarcoma Cells Can Be Sensitized to Temozolomide and to a Lesser Extent to Radiotherapy by Co-treatment with a PARP-inhibitor (AG014699)2012
12345678910